These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28236800)

  • 1. Impact of the new handling recommendations for hazardous drugs in a hospital pharmacy service.
    García-Alcántara BG; Perelló Alomar C; Moreno Centeno E; Modamio P; Mariño EL; Delgado Sánchez O
    Farm Hosp; 2017 Mar; 41(2):257-269. PubMed ID: 28236800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safe procedure development to manage hazardous drugs in the workplace.
    Gaspar Carreño M; Achau Muñoz R; Torrico Martín F; Agún Gonzalez JJ; Sanchez Santos JC; Cercos Lletí AC; Ramos Orozco P
    Farm Hosp; 2017 Mar; 41(2):222-256. PubMed ID: 28236799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive tackling to the safe handling of hazardous drugs: a multidisciplinary approach to clinical practice.
    Vuelta-Arce M; Chiapella-Micó C; Mestre-Prad MT; Teixidó-Huerta X; Del Estal-Jiménez J; Rodríguez-Gías E; Guinovart-Alemany M
    Int J Occup Med Environ Health; 2020 Sep; 33(5):621-634. PubMed ID: 32716012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hazardous drugs: new challenges, new opportunities.
    Valero García S; López Briz E; Vila Clérigues N; Poveda Andrés JL
    Farm Hosp; 2016 Mar; 40(2):124-7. PubMed ID: 26980170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of evidence on handling hazardous drugs and Products in Urology Services; consensus document between the Spanish Urology Association and the Spanish Society of Health-System Pharmacists.
    Unda-Urzáiz M; Alonso-Herreros JM; Fernández-Gómez JM; Gaspar-Carreño M; Cozar-Olmos JM; Cercós Lleti AC
    Farm Hosp; 2018 Sep; 42(5):212-215. PubMed ID: 30173640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus to identify the dangerous drugs risks in hospital pharmacy services.
    Bernabeu-Martínez MÁ; García-Salom P; Burgos-San José A; Navarro-Ruiz A; Sanz-Valero J; Wanden-Berghe C
    Farm Hosp; 2020 Mar; 44(2):51-61. PubMed ID: 32452316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Handling hazardous drugs in health care. USP 800 brings new guidelines to hospital pharmacies.
    Bernstein WN
    Health Facil Manage; 2016 Nov; 29(11):41-3. PubMed ID: 29490128
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementation of a safety program for handling hazardous drugs in a community hospital.
    Massoomi FF; Neff B; Pick A; Danekas P
    Am J Health Syst Pharm; 2008 May; 65(9):861-5. PubMed ID: 18436733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safe handling of hazardous drugs.
    Polovich M
    Online J Issues Nurs; 2004 Sep; 9(3):6. PubMed ID: 15482092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical approach to assess the hazardous exposure potential of investigational drugs.
    McLeod EN; Fillis CJ; Blind JE
    Am J Health Syst Pharm; 2020 Apr; 77(9):697-700. PubMed ID: 34278414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of closed systems in the Hospital Pharmacy.
    Forte Pérez-Minayo M; Castillo Bazán E; Hernández Segurado M; Arias Moya MÁ; Pelegrín Torres P; Bécares Martínez FJ
    Farm Hosp; 2016 Mar; 40(2):102-10. PubMed ID: 26980168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive program for handling hazardous drugs.
    Arrington DM; McDiarmid MA
    Am J Hosp Pharm; 1993 Jun; 50(6):1170-4. PubMed ID: 8517456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs.
    Dillon LR
    Int J Pharm Compd; 2020; 24(1):30-36. PubMed ID: 32023214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of surface contamination in a hospital hematology--oncology pharmacy.
    Touzin K; Bussières JF; Langlois E; Lefebvre M
    J Oncol Pharm Pract; 2009 Mar; 15(1):53-61. PubMed ID: 18772214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing workplace cytotoxic surface contamination using a closed-system drug transfer device.
    Siderov J; Kirsa S; McLauchlan R
    J Oncol Pharm Pract; 2010 Mar; 16(1):19-25. PubMed ID: 19965949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP <800>: Gaining Compliance Through Implementation of a Hazardous Drug Control Program.
    Blake K
    Clin J Oncol Nurs; 2019 Jun; 23(3):324-326. PubMed ID: 31099798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hazardous drugs.
    Black LA; Presson AC
    Occup Med; 1997; 12(4):669-85. PubMed ID: 9353816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to Precautionary Guidelines for Compounding Antineoplastic Drugs: A Survey of Nurses and Pharmacy Practitioners.
    Boiano JM; Steege AL; Sweeney MH
    J Occup Environ Hyg; 2015; 12(9):588-602. PubMed ID: 25897702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
    Valero-García S; González-Haba E; Gorgas-Torner MQ; Alonso-Herreros JM; Cercós Lletí AC; Poveda-Andrés JL; Calleja-Hernandez MÁ; Delgado-Sánchez O
    Farm Hosp; 2021 Mar; 45(2):96-107. PubMed ID: 33709894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization].
    Zuziak S; Topór-Madry R; Pilc A; Bochenek T
    Pol Merkur Lekarski; 2014 Jul; 37(217):43-8. PubMed ID: 25154199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.